These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31991193)

  • 1. In silico trials: Verification, validation and uncertainty quantification of predictive models used in the regulatory evaluation of biomedical products.
    Viceconti M; Pappalardo F; Rodriguez B; Horner M; Bischoff J; Musuamba Tshinanu F
    Methods; 2021 Jan; 185():120-127. PubMed ID: 31991193
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Jose J; S S; Mathew B; Parambi DGT
    Comb Chem High Throughput Screen; 2022; 25(12):1991-2000. PubMed ID: 34986768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Credibility of In Silico Trial Technologies-A Theoretical Framing.
    Viceconti M; Juarez MA; Curreli C; Pennisi M; Russo G; Pappalardo F
    IEEE J Biomed Health Inform; 2020 Jan; 24(1):4-13. PubMed ID: 31670687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model verification tools: a computational framework for verification assessment of mechanistic agent-based models.
    Russo G; Parasiliti Palumbo GA; Pennisi M; Pappalardo F
    BMC Bioinformatics; 2022 May; 22(Suppl 14):626. PubMed ID: 35590242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Critical Comparison of Comparators Used to Demonstrate Credibility of Physics-Based Numerical Spine Models.
    Stott B; Afshari P; Bischoff J; Clin J; Francois-Saint-Cyr A; Goodin M; Herrmann S; Liu X; Driscoll M
    Ann Biomed Eng; 2023 Jan; 51(1):150-162. PubMed ID: 36088433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility.
    Musuamba FT; Skottheim Rusten I; Lesage R; Russo G; Bursi R; Emili L; Wangorsch G; Manolis E; Karlsson KE; Kulesza A; Courcelles E; Boissel JP; Rousseau CF; Voisin EM; Alessandrello R; Curado N; Dall'ara E; Rodriguez B; Pappalardo F; Geris L
    CPT Pharmacometrics Syst Pharmacol; 2021 Aug; 10(8):804-825. PubMed ID: 34102034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Credibility Assessment Plan for an In Silico Model that Predicts the Dose-Response Relationship of New Tuberculosis Treatments.
    Curreli C; Di Salvatore V; Russo G; Pappalardo F; Viceconti M
    Ann Biomed Eng; 2023 Jan; 51(1):200-210. PubMed ID: 36115895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Credibility assessment of patient-specific computational modeling using patient-specific cardiac modeling as an exemplar.
    Galappaththige S; Gray RA; Costa CM; Niederer S; Pathmanathan P
    PLoS Comput Biol; 2022 Oct; 18(10):e1010541. PubMed ID: 36215228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible Contexts of Use for In Silico Trials Methodologies: A Consensus-Based Review.
    Viceconti M; Emili L; Afshari P; Courcelles E; Curreli C; Famaey N; Geris L; Horner M; Jori MC; Kulesza A; Loewe A; Neidlin M; Reiterer M; Rousseau CF; Russo G; Sonntag SJ; Voisin EM; Pappalardo F
    IEEE J Biomed Health Inform; 2021 Oct; 25(10):3977-3982. PubMed ID: 34161248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A framework to establish credibility of computational models in biology.
    Patterson EA; Whelan MP
    Prog Biophys Mol Biol; 2017 Oct; 129():13-19. PubMed ID: 27702656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verification and Validation of Computational Models Used in Biopharmaceutical Manufacturing: Potential Application of the ASME Verification and Validation 40 Standard and FDA Proposed AI/ML Model Life Cycle Management Framework.
    Bideault G; Scaccia A; Zahel T; Landertinger RW; Daluwatte C
    J Pharm Sci; 2021 Apr; 110(4):1540-1544. PubMed ID: 33493480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico clinical trials: concepts and early adoptions.
    Pappalardo F; Russo G; Tshinanu FM; Viceconti M
    Brief Bioinform; 2019 Sep; 20(5):1699-1708. PubMed ID: 29868882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Credibility Evidence for Computational Patient Models Used in the Development of Physiological Closed-Loop Controlled Devices for Critical Care Medicine.
    Parvinian B; Pathmanathan P; Daluwatte C; Yaghouby F; Gray RA; Weininger S; Morrison TM; Scully CG
    Front Physiol; 2019; 10():220. PubMed ID: 30971934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consideration of a Credibility Assessment Framework in Model-Informed Drug Development: Potential Application to Physiologically-Based Pharmacokinetic Modeling and Simulation.
    Kuemmel C; Yang Y; Zhang X; Florian J; Zhu H; Tegenge M; Huang SM; Wang Y; Morrison T; Zineh I
    CPT Pharmacometrics Syst Pharmacol; 2020 Jan; 9(1):21-28. PubMed ID: 31652029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approval of Cancer Drugs With Uncertain Therapeutic Value: A Comparison of Regulatory Decisions in Europe and the United States.
    Salcher-Konrad M; Naci H; Davis C
    Milbank Q; 2020 Dec; 98(4):1219-1256. PubMed ID: 33021339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).
    Pfaar O; Bachert C; Bufe A; Buhl R; Ebner C; Eng P; Friedrichs F; Fuchs T; Hamelmann E; Hartwig-Bade D; Hering T; Huttegger I; Jung K; Klimek L; Kopp MV; Merk H; Rabe U; Saloga J; Schmid-Grendelmeier P; Schuster A; Schwerk N; Sitter H; Umpfenbach U; Wedi B; Wöhrl S; Worm M; Kleine-Tebbe J; Kaul S; Schwalfenberg A
    Allergo J Int; 2014; 23(8):282-319. PubMed ID: 26120539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncertainty quantification patterns for multiscale models.
    Ye D; Veen L; Nikishova A; Lakhlili J; Edeling W; Luk OO; Krzhizhanovskaya VV; Hoekstra AG
    Philos Trans A Math Phys Eng Sci; 2021 May; 379(2197):20200072. PubMed ID: 33775139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is my model good enough? Best practices for verification and validation of musculoskeletal models and simulations of movement.
    Hicks JL; Uchida TK; Seth A; Rajagopal A; Delp SL
    J Biomech Eng; 2015 Feb; 137(2):020905. PubMed ID: 25474098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.